Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Beth Kennedy

Beth is editor at C+D. Having completed a masters' in magazine journalism from Cardiff University in 2014, she joined C+D as a reporter later that same year. Beth left C+D to edit multiple magazines for healthcare professionals in late 2016 and returned to C+D in February 2020. Specialist areas include the pharmacuetical supply chain and pharmacy regulation.

Latest Content

Lloydspharmacy quits the high street: It’s the end of the world as we know it

As what was once one of the largest community pharmacy chains in the UK announces it has exited the market, Beth Kennedy reflects on a turbulent year for Lloydspharmacy

Businesses General Business

All the headlines: Primary care recovery plan funding details revealed

Find out everything you need to know about how the government will split its £645 million investment into community pharmacy services – plus, the launch dates for Pharmacy First and a new contraception service.

Commissioning bodies Contract

‘Musical chairs gone wrong’: We need a pharmacy minister to stay the course

Beth Kennedy looks back over a tumultuous few years in healthcare policy as yet another pharmacy minister bites the dust

Businesses General Business

Stop retailers from offering multi-buy paracetamol deals, RPS urges

The Royal Pharmaceutical Society (RPS) has urged the government to bring in new laws that would prevent retailers from offering multi-buy deals on paracetamol.

Medicines General Regulation